Companies: 10,795·Total market cap: $144.5T
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCONYSEHealthcare● Active
$15.18
$-0.28(-1.81%)
Market Cap$5.4B
P/E Ratio
52W High$18.915
52W Low$11.44
Overview

Bausch + Lomb Corporation (BLCO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BLCO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.62blco eps ttm · blco earnings per shareEarnings history
PE Ratio (TTM)blco pe ratio ttm · blco price to earningsPE Ratio deep dive
Revenue (TTM)$5.2Bblco revenue ttm · blco annual revenueFull revenue history
Dividend YieldNo Dividenddoes blco pay dividends · blco dividend yieldDividend history
Shares Outstanding353.8Mblco shares outstanding · blco floatShares outstanding history
Next EarningsJul 29, 2026Est.blco earnings date · blco next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$5.10B▲ +6.47% YoY
202320242025
bausch + lomb corporation revenue · blco revenue 2025
FY 2025Net Income-$360.0M▼ 13.56% YoY
202320242025
bausch + lomb corporation net income · blco profit 2025
FY 2025EPS$-1.02▼ 13.33% YoY
202320242025
blco eps · bausch + lomb corporation earnings per share 2025
TTM:Revenue: $5.21BNet Income: -$219.0MEPS: $-0.62View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold16 analystsis blco a buy · blco analyst rating
Strong Buy
0
Buy
7
Hold
8
Sell
1
Strong Sell
0
12-Month Price Target
$16.00Low
$15.18Current
$18.57Avg Target22.33% upside
$21.00High
blco price target · blco 12 month forecast

Total: 16 · Buy rate: 43.8%

The BLCO analyst consensus is Hold, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $18.57, representing +22.33% upside from the current price of $15.18.

Stock Performance

Full History
1D-0.10%
1W+3.80%
1M-4.54%
3M-9.47%
YTD-9.57%
1Y+28.92%
5Y-22.77%

About Bausch + Lomb Corporation

CEOBrenton L. Saunders
IPO DateMay 6, 2022
Employees13,500
CountryCA
Websitebausch.com

Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. Th…

what is bausch + lomb corporation · blco stock overview · bausch + lomb corporation company profile · who is bausch + lomb corporation ceo · blco NYSE · bausch + lomb corporation headquarters · bausch + lomb corporation business segments

About Stock Overview & Key Data

Bausch + Lomb Corporation (BLCO) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since May 6, 2022. As of the latest trading session, BLCO stock price is $15.18, with a market capitalization of $5.4B. The stock has returned +28.92% over the past 12 months and -9.57% year-to-date.

According to 16 Wall Street analysts, the consensus rating for Bausch + Lomb Corporation stock is Hold, with an average 12-month price target of $18.57. In fiscal year 2025, Bausch + Lomb Corporation reported revenue of $5.1B and net income of -$360.0M. For detailed data — including Bausch + Lomb Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bausch + Lomb Corporation (BLCO) stock price is $15.18. The stock is traded on NYSE under the ticker symbol BLCO. The 52-week range is $11.44 – $18.91.

BLCO stock priceBLCO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice